Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients
| 針對症狀 | Hepatocellular Carcinoma |
| 臨床試驗編號 | NCT00699816 |
| 臨床階段 | Phase III |
| 臨床試驗位址 | 5 Study Locations |
| 目前研究進度 | This study has been completed. |
| 試驗開始日期 | June 17, 2008 |
| 試驗開始日期 | December 14, 2012 |
| 臨床目的 |
To prove that the efficacy and safety of 'INNOCELL* Immuncell-LC group' is superior to 'non-treatment group' in patient undergone curative resection (PEIT, RFA or operation) for hepatocellular carcinoma in Korea |